Home / News / Product News
Letrogen (Letrozole USP) - A third generation aromatase inhibitor
Letrozole is a third generation aromatase inhibitor. It is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer and advanced breast cancer. It is also a promising drug for ovulation induction in PCOS women and a better treatment option for endometriosis. It is available as 2.5mg tablet in 10's pack.